The Potential of MicroRNAs as Prostate Cancer Biomarkers.
Fabris, Linda ; Ceder, Yvonne LU
; Chinnaiyan, Arul M
; Jenster, Guido W
; Sorensen, Karina D
; Tomlins, Scott
; Visakorpi, Tapio
and Calin, George A
(2016)
In European Urology
70(2).
p.312-322
- Abstract
- Short noncoding RNAs known as microRNAs (miRNAs) control protein expression through the degradation of RNA or the inhibition of protein translation. The miRNAs influence a wide range of biologic processes and are often deregulated in cancer. This family of small RNAs constitutes potentially valuable markers for the diagnosis, prognosis, and therapeutic choices in prostate cancer (PCa) patients, as well as potential drugs (miRNA mimics) or drug targets (anti-miRNAs) in PCa management.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8573835
- author
- Fabris, Linda
; Ceder, Yvonne
LU
; Chinnaiyan, Arul M
; Jenster, Guido W
; Sorensen, Karina D
; Tomlins, Scott
; Visakorpi, Tapio
and Calin, George A
- organization
- publishing date
- 2016-01-21
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Urology
- volume
- 70
- issue
- 2
- pages
- 312 - 322
- publisher
- Elsevier
- external identifiers
-
- pmid:26806656
- scopus:84956950750
- pmid:26806656
- wos:000378206600031
- ISSN
- 1873-7560
- DOI
- 10.1016/j.eururo.2015.12.054
- language
- English
- LU publication?
- yes
- id
- 3db993e8-c623-4e9c-ac6d-c2dd75718d30 (old id 8573835)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26806656?dopt=Abstract
- date added to LUP
- 2016-04-04 09:09:47
- date last changed
- 2022-05-16 22:44:45
@article{3db993e8-c623-4e9c-ac6d-c2dd75718d30,
abstract = {{Short noncoding RNAs known as microRNAs (miRNAs) control protein expression through the degradation of RNA or the inhibition of protein translation. The miRNAs influence a wide range of biologic processes and are often deregulated in cancer. This family of small RNAs constitutes potentially valuable markers for the diagnosis, prognosis, and therapeutic choices in prostate cancer (PCa) patients, as well as potential drugs (miRNA mimics) or drug targets (anti-miRNAs) in PCa management.}},
author = {{Fabris, Linda and Ceder, Yvonne and Chinnaiyan, Arul M and Jenster, Guido W and Sorensen, Karina D and Tomlins, Scott and Visakorpi, Tapio and Calin, George A}},
issn = {{1873-7560}},
language = {{eng}},
month = {{01}},
number = {{2}},
pages = {{312--322}},
publisher = {{Elsevier}},
series = {{European Urology}},
title = {{The Potential of MicroRNAs as Prostate Cancer Biomarkers.}},
url = {{http://dx.doi.org/10.1016/j.eururo.2015.12.054}},
doi = {{10.1016/j.eururo.2015.12.054}},
volume = {{70}},
year = {{2016}},
}